The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Enflonsia (clesrovimab-cfor) injection, to safeguard newborn infants from respiratory syncytial virus.
iStock
This Site is Intended for Healthcare Professionals Only
Search
AI Powered
Human content,
AI powered search.
Latest Stories
Start your day right!
Get the latest updates and insights delivered to your inbox
Pharmacy2U recently crossed the milestone of two million patients, unveiled its new app and health hub, and relaunched its branded Pet Health service.
SAYOVE
The NHS carried out nearly seven million bowel cancer screenings during 2024/25, saving the lives of tens of thousands of people.
iStock
Dr Emily Kennedy
Royal College of Pharmacy
×
Terms and Conditions
By clicking the 'Subscribe’, you agree to receive our newsletter, marketing communications and industry
partners/sponsors sharing promotional product information via email and print communication from Asian Trade
Publications Ltd and subsidiaries. You have the right to withdraw your consent at any time by clicking the
unsubscribe link in our emails. We will use your email address to personalize our communications and send you
relevant offers. Your data will be stored up to 30 days after unsubscribing.
Contact us at
data@amg.biz
to see how we manage and store your data.
×
Terms and Conditions
By clicking the 'Subscribe’, you agree to receive our newsletter, marketing communications and industry
partners/sponsors sharing promotional product information via email and print communication from Asian Trade
Publications Ltd and subsidiaries. You have the right to withdraw your consent at any time by clicking the
unsubscribe link in our emails. We will use your email address to personalize our communications and send you
relevant offers. Your data will be stored up to 30 days after unsubscribing.
Contact us at data@amg.biz to see how we manage and store your data.